A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

NCT02650505 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: LEO 43204
DRUG: LEO 43204 Vehicle

Sponsor

LEO Pharma